These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Sortilin in Biliary Epithelial Cells Promotes Ductular Reaction and Fibrosis during Cholestatic Injury. Hubel E; Neumann A; Fishman S; Schaffer O; Erez N; Shrkihe BA; Shteingard Y; Gross T; Shibolet O; Varol C; Zvibel I Am J Pathol; 2024 Jun; 194(6):941-957. PubMed ID: 38493927 [TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice. Hartmann P; Haimerl M; Mazagova M; Brenner DA; Schnabl B Gastroenterology; 2012 Nov; 143(5):1330-1340.e1. PubMed ID: 22841787 [TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of hepatic cyclooxygenase-2 expression against cholestatic injury after common bile duct ligation in mice. Brea R; Casanova N; Alvarez-Lucena C; Fuertes-Agudo M; Luque-Tevar M; Cucarella C; Capitani MC; Marinochi MV; Fusini ME; Lahoz A; Nogueroles ML; Fraile J; Ronco MT; Boscá L; González-Rodríguez Á; García-Monzón C; Martín-Sanz P; Casado M; Francés DE Liver Int; 2024 Jun; ():. PubMed ID: 38847511 [TBL] [Abstract][Full Text] [Related]
10. Increased oxidative stress and apoptosis in the hypothalamus of diabetic male mice in the insulin receptor substrate-2 knockout model. Baquedano E; Burgos-Ramos E; Canelles S; González-Rodríguez A; Chowen JA; Argente J; Barrios V; Valverde AM; Frago LM Dis Model Mech; 2016 May; 9(5):573-83. PubMed ID: 27013528 [TBL] [Abstract][Full Text] [Related]
11. IGF-1R contributes to stress-induced hepatocellular damage in experimental cholestasis. Cadoret A; Rey C; Wendum D; Elriz K; Tronche F; Holzenberger M; Housset C Am J Pathol; 2009 Aug; 175(2):627-35. PubMed ID: 19628767 [TBL] [Abstract][Full Text] [Related]
12. FGF21-dependent alleviation of cholestasis-induced liver fibrosis by sodium butyrate. Yang J; Chen L; Zhao SS; Du C; Fan YZ; Liu HX; Li Y; Li YZ Front Pharmacol; 2024; 15():1422770. PubMed ID: 39040469 [TBL] [Abstract][Full Text] [Related]
13. Role of gut/liver metabolites and gut microbiota in liver fibrosis caused by cholestasis. Xie XM; Feng S; Liu T; Feng J; Xu Y; Fan ZJ; Wang GY Int Immunopharmacol; 2024 Jul; 139():112747. PubMed ID: 39067396 [TBL] [Abstract][Full Text] [Related]
14. Effects and potential mechanisms of IGF1/IGF1R in the liver fibrosis: A review. Gui R; Li W; Li Z; Wang H; Wu Y; Jiao W; Zhao G; Shen Y; Wang L; Zhang J; Chen S; Hao L; Cheng Y Int J Biol Macromol; 2023 Nov; 251():126263. PubMed ID: 37567540 [TBL] [Abstract][Full Text] [Related]
15. An optimized visualization and quantitative protocol for in-depth evaluation of lymphatic vessel architecture in the liver. Jeong J; Tanaka M; Yang Y; Arefyev N; DiRito J; Tietjen G; Zhang X; McConnell MJ; Utsumi T; Iwakiri Y Am J Physiol Gastrointest Liver Physiol; 2023 Nov; 325(5):G379-G390. PubMed ID: 37605828 [TBL] [Abstract][Full Text] [Related]
16. Transcriptotype-Driven Discovery of Apigenin as a Therapy against Cholestatic Liver Fibrosis: Through Inhibition of PANoptosis and Following Type-I Interferon Responses. Duan S; Li X; Han J; Yang Y; Luo R; Cai Y; Li X; Zheng Q; Guo J; Liu R Antioxidants (Basel); 2024 Feb; 13(3):. PubMed ID: 38539789 [TBL] [Abstract][Full Text] [Related]
17. Cellular crosstalk during cholestatic liver injury. Thomson J; Hargrove L; Kennedy L; Demieville J; Francis H Liver Res; 2017 Jun; 1(1):26-33. PubMed ID: 29552372 [TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine phosphatase 1b deficiency protects against hepatic fibrosis by modulating nadph oxidases. García-Ruiz I; Blanes Ruiz N; Rada P; Pardo V; Ruiz L; Blas-García A; Valdecantos MP; Grau Sanz M; Solís Herruzo JA; Valverde ÁM Redox Biol; 2019 Sep; 26():101263. PubMed ID: 31299613 [TBL] [Abstract][Full Text] [Related]
19. Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis. Marañón P; Isaza SC; Fernández-García CE; Rey E; Gallego-Durán R; Montero-Vallejo R; de Cía JR; Ampuero J; Valverde ÁM; Romero-Gómez M; García-Monzón C; González-Rodríguez Á Biomark Res; 2023 Apr; 11(1):46. PubMed ID: 37106416 [TBL] [Abstract][Full Text] [Related]
20. Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway Zhao H; Lu J; He F; Wang M; Yan Y; Chen B; Xie D; Xu C; Wang Q; Liu W; Yu W; Xi Y; Yu L; Yamamoto T; Koyama H; Wang W; Zhang C; Cheng J Front Immunol; 2022; 13():931087. PubMed ID: 36177037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]